Pulmonary edema primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Effective measures for the primary prevention of cardiogenic pulmonary edema include maintaining a healthy lifestyle, avoid tobacco, treat [[dyslipidemia]], low salt diet, controlling [[hypertension]], avoid [[cardiotoxic]] agents, controling [[diabetes]]. Effective measures for the primary prevention of high-altitude pulmonary edema include, encourage healthy lifestyle and exercise, gradual ascent, preacclimization, avoiding alcohol ingestion, high carbohydrate in diet, adequate [[hydration]], vigorous exertion during the first few days at high altitude, [[oxygen]] enrichment.
Effective measures for the primary prevention of cardiogenic pulmonary edema include maintaining a healthy lifestyle, avoid tobacco, treat [[dyslipidemia]], low salt diet, controlling [[hypertension]], avoid [[cardiotoxic]] agents, controling [[diabetes]]. Effective measures for the primary prevention of [[Altitude sickness|high-altitude]] pulmonary edema include, encourage healthy lifestyle and exercise, gradual ascent, preacclimization, avoiding alcohol ingestion, high [[carbohydrate]] in diet, adequate [[hydration]], vigorous exertion during the first few days at high altitude, [[oxygen]] enrichment.


==Primary Prevention==
==Primary Prevention==
Line 20: Line 20:
* Controling diabetes
* Controling diabetes
Consider additional measures in selected patients:
Consider additional measures in selected patients:
* Administer [[ACE-I]] if history of [[MI]] or [[ACS]] and reduced [[EF]] to prevent symptoms and reduce mortality
* Administer [[ACE-I]] if history of [[myocardial infarction]] or [[ACS]] and reduced [[ejection fraction]] to prevent symptoms and reduce mortality
* Administer [[Beta-blocker|beta-blockers]] if history of [[MI]] or [[ACS]] and reduced [[EF]] to reduce mortality in all reduced [[EF]]<nowiki/>to prevent symptoms
* Administer [[Beta-blocker|beta-blockers]] if history of  [[myocardial infarction]] or [[ACS]] and reduced [[ejection fraction]] to reduce mortality 
* Administer [[Statin|statins]] if history of [[MI]] or [[ACS]] to prevent symptoms
* Administer [[Statin|statins]] if history of [[MI|<nowiki/>]] [[myocardial infarction]] or [[ACS]] to prevent symptoms
* Consider [[ICD]] placement to prevent sudden death if asymptomatic ischemic [[cardiomyopathy]], > 40 days post-MI, [[LVEF]] ≤30%, on adequate medical therapy, and good 1 year survival
* Consider [[ICD]] placement to prevent sudden death if asymptomatic ischemic [[cardiomyopathy]], > 40 days post-MI, [[LVEF]] ≤30%, on adequate medical therapy, and good 1 year survival



Revision as of 14:41, 16 March 2018

Pulmonary edema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Edema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

Electrocardiography

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventional Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary edema primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary edema primary prevention

CDC on Pulmonary edema primary prevention

Pulmonary edema primary prevention in the news

Blogs on Pulmonary edema primary prevention

Directions to Hospitals Treating Pulmonary edema

Risk calculators and risk factors for Pulmonary edema primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]

Overview

Effective measures for the primary prevention of cardiogenic pulmonary edema include maintaining a healthy lifestyle, avoid tobacco, treat dyslipidemia, low salt diet, controlling hypertension, avoid cardiotoxic agents, controling diabetes. Effective measures for the primary prevention of high-altitude pulmonary edema include, encourage healthy lifestyle and exercise, gradual ascent, preacclimization, avoiding alcohol ingestion, high carbohydrate in diet, adequate hydration, vigorous exertion during the first few days at high altitude, oxygen enrichment.

Primary Prevention

Cardiogenic pulmonary edmea

Cardiogenic pulmonary edema is due to heart-related illnesses. Primary prevention include:[1]

  • Maintaining a healthy lifestyle
  • Avoid tobacco
  • Treat dyslipidemia
  • Low salt diet
  • Controlling hypertension
  •  Avoid cardiotoxic agents
  • Controling diabetes

Consider additional measures in selected patients:

Non-cardiogenic pulmonary edema

  • High-altitude pulmonary edema
    • Effective measures for the primary prevention of altitude sickness include:[2][3]
      • Encourage healthy lifestyle and exercise
      • Gradual ascent
      • Preacclimization
      • Avoiding alcohol ingestion
      • High carbohydrate in diet
      • Adequate hydration
      • Vigorous exertion during the first few days at high altitude
      • Oxygen enrichment
      • Druges
        • Ibuprofen
        • Acetazolamide
        • Sumatriptan
        • Sprinolactone
        • Steroids
  • Acute respiratory distress syndrome
    • For more information about primary intervention in acute respiratory distress syndrome click here.

References

  1. Ware LB, Matthay MA (December 2005). "Clinical practice. Acute pulmonary edema". N. Engl. J. Med. 353 (26): 2788–96. doi:10.1056/NEJMcp052699. PMID 16382065.
  2. Taylor AT (January 2011). "High-altitude illnesses: physiology, risk factors, prevention, and treatment". Rambam Maimonides Med J. 2 (1): e0022. doi:10.5041/RMMJ.10022. PMC 3678789. PMID 23908794.
  3. Murdoch D (March 2010). "Altitude sickness". BMJ Clin Evid. 2010. PMC 2907615. PMID 21718562.


Template:WikiDoc Sources